[Hereditary Cancer in Clinical Practice] Scientists provide a review of the emerging preclinical and epidemiologic evidence implicating the dysregulation of progesterone-mediated receptor activator of nuclear factor κB signaling in the pathogenesis of BRCA1-associated breast cancer.
[Clinical and Translational Medicine] Investigators explored the impacts of prostate cancer-associated ncRNA transcripts 1 (PCAT1) on tumorigenesis and radioimmune responses and the underlying molecular mechanisms in NSCLC.
[Cell Reports] The authors transplanted organoid cells derived from alveolar type II cells enriched by SCA1-negative status or multipotent SCA1-positive progenitor cells into injured mouse lungs.
[Molecular Cancer Research] A transgenic mouse model expressing human Caspase-9b in the lung pneumocytes developed inflammatory lung lesions, which correlated with enhanced activation of the NF-κB pathway and increased influx of immunosuppressive MDSCs in contrast to wild-type mice.
[Clinical Cancer Research] A retrospective database query identified patients with KRAS-mutant NSCLC to understand their propensity to develop brain metastases.
[Journal For Immunotherapy of Cancer] Researchers supported the rational design of immunotherapeutic strategies targeting cancer stem cells to optimize their responsiveness to local CD8+CD103+ TRM cells for more efficient anticancer treatments.
[Scientific Reports] Scientists treated pancreatic stellate cells with conditioned medium from various pancreatic cancer cells (CCM). They revealed that CCM consistently activates STAT3 to secrete muscle atrophy-inducing factors from stellate cells and that the secretion was not observed when CCM from brefeldin A-treated cancer cells was added.
[Communications Biology] The authors investigated the role of isofalcarintriol (IFT), a carrot-derived polyacetylene, in regulating mitochondrial function in gestational diabetes mellitus-related β-cells.
[University of Oklahoma] With a five-year, $2.6 million grant from the National Cancer Institute, Dr. Kamiya Mehla will investigate how a diet high in saturated fats may contribute to tumor growth by weakening the body’s anti-tumor immune response and changing how cancer cells use fats.